Diabetes and Cancer‐Specific Survival: A Nationwide Population‐Based Cohort Study Across Multiple Cancer Sites
Cancer Reports · 2026-06 · 9 (6)
DOI: 10.1002/cnr2.70615 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Reports, online erschienen am 18.06.2026. Verfasst von Petrus Lohi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tampere University, Faculty of Social Sciences, Tampere, Finland. Hauptthemen laut MEDLINE: Neoplasms, Diabetes Mellitus, Type 2. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetestutkimussäätiö, Seventh Framework Programme, Syöpäsäätiö.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Cancer patients with concurrent diabetes generally show poorer survival compared with nondiabetic patients.
Aims
We examined the relationship between Type 2 diabetes and cancer‐specific survival in the 13 most common cancer sites within a large population‐based cohort in Finland. We hypothesized that survival would be lower among patients with diabetes across cancer types. Methods and Results The cohort, derived from the Finnish CARING Project, included 49 799 incident cancer cases: 25 899 in patients with diabetes and 23 900 in nondiabetic patients. The mean age at diagnosis was 72.2 years, and 40.9% were women. During a mean follow‐up of 3.8 years (188 329 person‐years), 13 602 cancer deaths occurred. The impact of diabetes on prognosis varied by cancer type. Survival was substantially lower for stomach, endometrial, and lympho‐hematological cancers, and slightly lower for colon and breast cancer. Conversely, patients with diabetes had higher survival for liver and rectal cancer. No notable differences were observed for pancreatic, bladder, kidney, prostate, lung, or nonmelanoma skin cancer.
Conclusion
Future studies should focus on the biological and metabolic factors influencing cancer survival in patients with diabetes and on how treatment strategies can be optimized to reduce excess cancer mortality in this patient group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tampere University, Faculty of Social Sciences, Tampere, Finland.
- Department of Public Health, University of Helsinki, Helsinki, Finland.
- Department of Endocrinology, Päijät-Häme Central Hospital, Lahti, Finland.
- University of Eastern Finland, Kuopio, Finland.
ORCID-Profile: Petrus Lohi, Jari Haukka, Leo Niskanen, Anssi Auvinen
Förderung
- Diabetestutkimussäätiö
- Seventh Framework Programme
- Syöpäsäätiö
Zitieren
APA
Lohi, P., Haukka, J., Niskanen, L., & Auvinen, A. (2026). Diabetes and Cancer‐Specific Survival: A Nationwide Population‐Based Cohort Study Across Multiple Cancer Sites. Cancer Reports, 9(6). https://doi.org/10.1002/cnr2.70615
Vancouver
Lohi P, Haukka J, Niskanen L, Auvinen A. Diabetes and Cancer‐Specific Survival: A Nationwide Population‐Based Cohort Study Across Multiple Cancer Sites. Cancer Reports. 2026;9(6). doi:10.1002/cnr2.70615
BibTeX
@article{Lohi2026,
author = {Lohi, Petrus and Haukka, Jari and Niskanen, Leo and Auvinen, Anssi},
title = {Diabetes and Cancer‐Specific Survival: A Nationwide Population‐Based Cohort Study Across Multiple Cancer Sites},
journal = {Cancer Reports},
year = {2026},
volume = {9},
number = {6},
doi = {10.1002/cnr2.70615}
}
EUVIMED